Clinical Trial Update: HCQ in Resectable Localized Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Hydroxychloroquine is being studied in an early-phase (Phase 1) trial for resectable localized prostate cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Lionel.D.Lewis, MD | Conditions: Resectable Localized Prostate Cancer | EARLY_Phase 1 | Status: RECRUITING